Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

Although outbreaks of Ebola virus are rare, the disease is severe and often fatal, with few treatment options. Rather than ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...

Scientists report that a class of drugs, called RNA interference (RNAi) therapeutics, represent a major advancement in the ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, B.C., July 29, 2025 /PRNewswire/ -- Equity Insider News Commentary – ...

Akkermansia muciniphila (Akk) has gained significant attention for its role in regulating metabolic health and its impact on ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Gilead ...

A chronic hepatitis B treatment program has helped over 10,000 patients achieve a functional cure — also known as clinical ...

Assembly Biosciences, Inc. (NASDAQ:ASMB) is one of the growth stocks that could double by 2027. On June 25, the company ...